This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Sc in a quasi-generator system are crucial for enabling its medical application. RESULTS: eluate remained suitable for radiolabelling for the entire testing period of up to 4 days post-elution. Trace metal analysis showed predominantly low contamination levels, with sporadic impurities attributed to handling conditions. CONCLUSIONS: Sc as a radionuclide precursor was proposed following the European Pharmacopoeia guidelines, providing a groundwork for future standardisation.
No takes yet. Share an insight, caveat, or question.
Cieszykowska et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: